Re20
Re20
Human Acellular Dermal Matrix Skin Booster
Re2O Skin Booster
Re2O is an injectable skin-booster product made from micronized human acellular dermal matrix, also called hADM. The material contains components of the skin’s extracellular matrix and is marketed in selected international aesthetic markets for skin-quality and structural-support treatments. At DermaPhi, any use would require careful review of the exact product, sourcing, patient eligibility, and legal and regulatory status in the treatment location.
Product Category
Human-Tissue ECM Skin Booster
Treatment Style
Injectable, Structural & Skin-Quality Focused
What Is Re2O?
Re2O is produced from processed donated human dermal tissue. During manufacturing, cellular material is removed to create an acellular dermal matrix while preserving structural extracellular-matrix components. The product is then micronized for injectable use. It is different from hyaluronic-acid filler, polynucleotide products, and collagen-stimulating polymers.
Potential Treatment Goals
Skin-Density Support
May be considered in markets where authorized for patients seeking gradual improvement in the appearance of thin or weakened-looking skin.
Texture Refinement
May support smoother-looking texture and a more even skin surface as part of a planned treatment series.
Elasticity & Firmness
May be incorporated into a skin-quality plan focused on firmness, resilience, and the appearance of fine crepiness.
Subtle Structural Support
Is marketed as a dermal-matrix treatment rather than a conventional volumizing filler, although technique and placement can affect contour.
Commonly Discussed Treatment Areas
How Re2O Differs From Other Skin Boosters
Skin boosters are not interchangeable. Each category uses a different material and may have a different mechanism, risk profile, authorized use, and level of supporting evidence.
Re2O
Human Acellular Dermal MatrixProvides processed extracellular-matrix material derived from donated human dermis rather than relying only on hydration or a signaling ingredient.
Rejuran
Polynucleotide ProductUses polynucleotide material and is generally marketed for gradual skin-quality support rather than direct matrix replacement.
Traditional Fillers
Volume & ContourMost commonly use materials such as hyaluronic acid or calcium hydroxylapatite to create defined filling, smoothing, or contour effects.
Your Treatment Experience
Consultation
Your provider reviews your skin, anatomy, allergies, medications, medical history, prior procedures, and treatment expectations.
Customized Placement
The product is prepared and placed using an injection technique selected for the treatment area and intended depth.
Recovery & Follow-Up
You receive aftercare instructions and follow-up based on swelling, bruising, skin response, and the proposed treatment plan.
Human-Tissue Product Verification Matters
Re2O is a human-tissue-derived product. Patients should receive clear information about donor screening, tissue processing, sterility, storage, handling, traceability, intended use, and the product’s regulatory status in the country where treatment is performed.
Important Information for U.S. Patients
Do not assume that international availability means a product is FDA approved for cosmetic injection in the United States. Before treatment, ask the clinic to identify the exact FDA authorization, approval, or applicable regulatory pathway for the product and proposed use. FDA recommends using only approved injectable fillers for their authorized indications and warns that unapproved injectable products may not have established safety or effectiveness.
Frequently Asked Questions
Is it called RE20 or Re2O?
The manufacturer styles the product name as Re2O, using the letter “O.” The name is sometimes informally typed as RE20 because the characters look similar.
Is Re2O the same as dermal filler?
No. Re2O is described by its manufacturer as micronized human acellular dermal matrix. Conventional FDA-approved dermal fillers generally use materials such as hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, or PMMA for specific approved indications.
Is Re2O made from human tissue?
Yes. Manufacturer information describes Re2O as processed human acellular dermal matrix derived from donated human skin tissue.
How many treatments will I need?
Treatment schedules reported by international clinics vary. The number and spacing of sessions should be based on the exact product instructions, treatment area, response, and local authorization.
What downtime should I expect?
Injection-related effects may include temporary bumps, redness, swelling, tenderness, bruising, itching, or discomfort. Recovery varies by depth, volume, area, and technique.
Can Re2O be used under the eyes?
Delicate areas require specialized assessment. The under-eye region carries risks related to swelling, visible irregularity, vascular injury, and product placement. Use should match the exact product’s authorized instructions.
Can Re2O be combined with lasers or RF treatments?
Combination treatment may increase inflammation or affect healing. Timing should be determined by a qualified provider using the exact device and product instructions rather than a standard package.
Is Re2O FDA approved for cosmetic injection?
Patients should not assume FDA approval. Ask the clinic for the exact product record and the specific U.S. authorization or approval that applies to cosmetic injection and the proposed treatment area.
Is Re2O appropriate for everyone?
No. Pregnancy, breastfeeding, active infection, immune conditions, bleeding disorders, allergies, medications, prior reactions to human-tissue products, and other health factors may affect eligibility.
Re2O is a human-tissue-derived injectable product whose availability, classification, intended use, and regulatory status vary by country. This page is educational and does not represent an offer to administer an unapproved product. Treatment should occur only where legally permitted, using verified product obtained through legitimate channels and administered by a qualified licensed professional. Potential risks include pain, redness, swelling, bruising, infection, inflammatory or immune reaction, nodules, vascular injury, tissue damage, scarring, pigment changes, contour irregularity, and an unsatisfactory result. Individual results vary.
